Instrument Inactif

Autres langues Furiex Pharmaceuticals Inc

Actions

US36106P1012

Recherche biotechnologique et médicale

Cours en clôture Nasdaq
- ^USD	-

28/04/14	Bank of America : Wall Street ouvre en hausse, les pharmaceutiques en vue	RE
28/04/14	Wall Street ouvre en hausse, les pharmaceutiques en vue	RE

Autres langues

02/07/14	Furiex Pharmaceuticals : Actavis Completes Acquisition of Furiex Pharmaceuticals
01/07/14	Furiex Pharmaceuticals : Stockholders Approve Acquisition by Actavis; Ukrainian Antimonopoly Committee Clears Proposed Merger
13/05/14	Furiex Pharmaceuticals : INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of Furiex Pharmaceuticals, Inc. of Claims Against Board of Directors of Company In Connection With the Sale of the Company to Forest Laboratories, Inc. -- FURX
07/05/14	Furiex Pharmaceuticals : Reports First Quarter 2014 Financial Results
06/05/14	Actavis : Factbox - M&A frenzy transforming global pharma
06/05/14	Actavis : M&A frenzy in healthcare sector
02/05/14	Furiex Pharmaceuticals : INVESTOR ALERT – FURIEX PHARMACEUTICALS, INC.: The Law Offices of Vincent Wong Investigates the Sale of Furiex Pharmaceuticals, Inc.
30/04/14	Furiex Pharmaceuticals : INVESTOR ALERT - FURIEX PHARMACEUTICALS, INC.: The Law Offices of Vincent Wong Investigates the Sale of Furiex Pharmaceuticals, Inc. -- FURX
29/04/14	Furiex Pharmaceuticals : Ryan & Maniskas, LLP : Announces Investigation of Furiex Pharmaceuticals, Inc.
29/04/14	Furiex Pharmaceuticals : INVESTOR ALERT Levi & Korsinsky, LLP Announces Investigation of Furiex Pharmaceuticals, Inc. and Its Board of Directors In Connection With the Sale of the Company to Forest Laboratories, Inc. -- FURX
29/04/14	Furiex Pharmaceuticals : Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Furiex Pharmaceuticals, Inc. Stockholders
28/04/14	Furiex Pharmaceuticals : Morgan & Morgan : Announces the Investigation of Furiex Pharmaceuticals, Inc. FURX
28/04/14	Furiex Pharmaceuticals : Stockholders Encouraged to Contact Securities Law Firm about Takeover
28/04/14	Furiex Pharmaceuticals : INVESTOR ALERT Levi & Korsinsky, LLP Announces Investigation of Furiex Pharmaceuticals, Inc. and Its Board of Directors In Connection With the Sale of the Company to Forest Laboratories, Inc.
28/04/14	Furiex Pharmaceuticals : INVESTOR ALERT Levi & Korsinsky, LLP Announces Investigation of Furiex Pharmaceuticals, Inc. and Its Board of Directors In Connection With the Sale of the Company to Forest Laboratories, Inc.
28/04/14	Furiex Pharmaceuticals : Newman Ferrara LLP : Announces Investigation of Furiex Pharmaceuticals, Inc.
28/04/14	Furiex Pharmaceuticals : ALERT: Proposed Buyout of Pharmaceuticals under Investigation by Johnson & Weaver, LLP
07/04/14	Furiex Pharmaceuticals : Announces First Quarter 2014 Earnings Release and Conference Call
03/04/14	Furiex Pharmaceuticals : Announces Acceptance to Late-Breaking Abstract Session at Digestive Disease Week 2014
27/03/14	Furiex Pharmaceuticals : Confirms Takeda Will Present Additional Data from the EXAMINE Trial at the American College of Cardiology's 63rd Annual Scientific Session
27/03/14	Furiex Pharmaceuticals : Confirms Takeda Will Present Additional Data from the EXAMINE Trial at the American College of Cardiology’s 63rd Annual Scientific Session
11/03/14	Furiex Pharmaceuticals Inc : Furiex Pharmaceuticals Reports Fourth Quarter and Full-Year 2013 Financial Results
07/03/14	Furiex Pharmaceuticals Inc : Furiex Pharmaceuticals Confirms Takeda's Submission of a New Drug Application for Trelagliptin Succinate (SYR-472) in Japan for the Treatment of Type 2 Diabetes
10/02/14	Furiex Pharmaceuticals Inc : Furiex Pharmaceuticals Announces Fourth Quarter 2013 Earnings Release and Conference Call
04/02/14	Furiex Pharmaceuticals Inc : Furiex Pharmaceuticals Announces Positive Top-Line Results of Two Pivotal Phase III Clinical Trials of Eluxadoline in Patients with IBS-d